Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed CFO Acq. announced Director departure Quarterly results Appointed director CC transcript
|
ILLUMINA, INC. (ILMN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/21/2020 |
8-K
| Quarterly results |
09/26/2019 |
8-K
| Acquisition/merger/asset purchase announced |
11/05/2018 |
8-K
| Acquisition/merger/asset purchase announced
Docs:
|
"Agreement and Plan of Merger, by and among Illumina, Inc., FC Ops Corp. and Pacific Biosciences of California, Inc",
"Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery • Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome • Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight • Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022",
"Form of Voting Agreement" |
|
01/10/2013 |
8-K
| Acquisition/merger/asset purchase announced |
|
|